Nov 10, 2020
Alzheimer's Association Should Reveal Financial Conflict of Interest in Urging FDA to Approve Biogen Drug, Says Dr. Leslie Norins, CEO of Alzheimer's Germ Quest
Jun 19, 2020
Global Spinal Muscular Atrophy Market Outlook to 2027 - Advent of Oral mRNA Splicer for Treatment
Jun 17, 2020
Leukemia Therapeutics Markets, 2015-2025 - Size by Value & Volume, Trends & Developments, Competitive Landscape
Jun 03, 2020
Doctors on the Front Lines Are Testing New Therapies to Treat COVID-19
Jun 02, 2020
World Markets for Interferons, 2030 (COVID-19 Adjusted) - Roche, Merck, BMS, Biogen, Bayer, Zydus Cadila, Novartis, Pfizer, Biosidus, and Nanogen are the Major Players
Jun 02, 2020
AstronauTx Announces an Alliance With Concept Life Sciences to Accelerate the Identification of Novel Therapies For Alzheimer's Disease
May 27, 2020
BrainStorm Appoints Pharmaceutical Veteran Stacy R. Lindborg, Ph.D. as Executive Vice President, Head of Global Clinical Research
May 18, 2020
Global Orphan Diseases Partnering 2010-2020: Deal Trends, Players and Financials
May 06, 2020
Ionis reports first quarter 2020 financial results and recent business achievements
Apr 30, 2020
Switching Patterns Among Relapsing-Remitting Multiple Sclerosis: Genentech's Ocrevus on the Rise, Biogen's Tecfidera Declines, and Teva's Copaxone Remains Strong, According to Spherix Global Insights
Apr 27, 2020
Graft Versus Host Disease (GvHD) Pipeline Guide, H1 2020
Apr 21, 2020
Multiple Sclerosis Drugs Industry Assessment 2020: Immunomodulators, Immunosuppressants, Interferons and Others
Apr 17, 2020
Visiongain Report: The Gene Therapy Market is Projected to Grow at a CAGR of 32% in the First Half of the Forecast Period
Apr 14, 2020
n-Lorem Foundation receives $500,000 donation for providing experimental antisense medicines to treat patients with ultra-rare diseases
Apr 09, 2020
Samsung Biologics and Vir Biotechnology Enter into Agreement for Large Scale Manufacture of SARS-COV-2 Antibodies for Potential COVID-19 Treatment
Apr 09, 2020
Roche's Ocrevus Continues to Impress in the EU with Strong Uptake in New Start and Switch Multiple Sclerosis Patient Segments, but Novartis' Mayzent and Ofatumumab May Threaten the Brand's Long-Term Dominance
Mar 30, 2020
Arena Pharmaceuticals Names James C. Mullen as an Independent Senior Advisor
Mar 24, 2020
Biosimilars Market Worth $35.7 Billion by 2025 - Exclusive Report by MarketsandMarkets(TM)
Mar 19, 2020
Multiple Sclerosis Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast (2019 to 2027)
Mar 13, 2020
Innovations Abound in the Fight Against COVID-19